• Search History (Register)
  • MeSH Browser
  • [Clear]
    • English

Welcome to the international HTA database


Showing [16861 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2004     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation
2004     NIHR Health Technology Assessment programme What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews
2004     NIHR Health Technology Assessment programme Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation
2004     HAYES, Inc. Positron emission tomography (PET) for Parkinson's disease
2004     NIHR Health Technology Assessment programme Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation
2004     NIHR Health Technology Assessment programme Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Cryotherapy for prostate cancer
2004     NIHR Health Technology Assessment programme Methods for identifying and classifying surgical site infection after discharge from hospital
2004     Finnish Office for Health Care Technology Assessment (Finohta) [Screening for rare metabolic disease in newborn infants]
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Quantitative approaches to patient safety. Research in risk analysis and risk management as applied to radiotherapy
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Diabetic testing
2004     Alberta Heritage Foundation for Medical Research (AHFMR) A selected inventory of abstracts of Cochrane reviews on physiotherapy/physical therapy - interim report for expert advisory panel and the research team
2004     New Zealand Health Technology Assessment (NZHTA) What is the evidence for the effectiveness of behavioural and skill-based early intervention in young children with autism spectrum disorder (ASD)?
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) EMDR for treatment of post-traumatic stress disorder
2004     NIHR Health Technology Assessment programme Involving South Asian patients in clinical trials
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Endometrial ablation for menorrhagia
2004     NIHR Health Technology Assessment programme The value of a QALY implied by the value of a 'statistical life' in the field of transport
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Interventional and intraoperative magnetic resonance imaging
2004     HAYES, Inc. Postoperative disposable ambulatory regional anesthesia
2004     NIHR Health Technology Assessment programme Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Insulin pen-fill formulations
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Profile of an HTA program: the AHFMR Health Technology Assessment Unit, 2002-2003
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Patient lift technologies
2004     Malaysian Health Technology Assessment Unit (MHTAU) Misoprostol in pregnancy
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Prolotherapy for the treatment of chronic musculoskeletal pain
2004     Malaysian Health Technology Assessment Unit (MHTAU) Screening for hearing loss in infants
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Thalidomide for the treatment of multiple myeloma
2004     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Screening for hearing loss in high risk babies
2004     Malaysian Health Technology Assessment Unit (MHTAU) Second generation endometrial ablation
2004     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Second generation endometrial ablation techniques
2004     NIHR Health Technology Assessment programme The relative societal value of health gains for different beneficiaries
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Advance directives for end-of-life care in the elderly - effectiveness of delivery modes
2004     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Use of ultrasound in antenatal and primary care
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Low level laser therapy for wound healing: an update
2004     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Screening for obesity in young population
2004     HAYES, Inc. Proton beam therapy
2004     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Prefabricated myo-functional appliance for treatment
2004     HAYES, Inc. Proton beam therapy for prostate cancer
2004     Agency for Healthcare Research and Quality (AHRQ) Meta-regression approaches: what, why, when, and how?
2004     ECRI B-type natriuretic peptide for diagnosing heart failure
2004     Agency for Healthcare Research and Quality (AHRQ) Closing the quality gap: a critical analysis of quality improvement strategies, volume 1 - series overview and methodology
2004     Agency for Healthcare Research and Quality (AHRQ) Closing the quality gap: a critical analysis of quality improvement strategies, volume 2 - diabetes mellitus care
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Use of cannabis or cannabinoids for non-malignant chronic pain
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Living donor liver transplantation in children
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Botulinum toxin type A injection for achalasia and anal fissure
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Botulinum toxin type A injection into the ilopsoas muscle
2004     HAYES, Inc. Radiofrequency ablation for chronic spinal pain
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Adult to adult living donor liver transplantation
2004     HAYES, Inc. Radiofrequency ablation for osteoid osteoma
2004     HAYES, Inc. Radiofrequency ablation for primary and metastatic cancers of the liver
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Standard quality assessment criteria for evaluating primary research papers from a variety of fields
2004     HAYES, Inc. Radiofrequency ablation for trigeminal neuralgia
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Knowledge brokers: linking researchers and policy makers
2004     Agency for Healthcare Research and Quality (AHRQ) Pharmacological treatment of dementia
2004     HAYES, Inc. Radiofrequency endometrial ablation for menorrhagia secondary to dysfunctional uterine bleeding
2004     University of York Effectiveness of antihypertensive drugs in black people
2004     Medical Advisory Secretariat (MAS) Bispectral index monitor: an evidence-based analysis
2004     Medical Advisory Secretariat (MAS) Primary angioplasty for the treatment of acute ST-segment elevated myocardial infarction: an evidence-based analysis
2004     NIHR Health Technology Assessment programme Identification and assessment of ongoing trials in health technology assessment reviews
2004     National Institute for Health and Care Excellence (NICE) Imatinib for the treatment of unresectable and/or metastatic gastro-intestinal stromal tumours. NICE technology appraisal guidance 86
2004     NIHR Health Technology Assessment programme Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine
2004     NIHR Health Technology Assessment programme Supplementation of a home-based exercise programme with a class-based programme for people with osteoarthritis of the knees: a randomised controlled trial and health economic analysis
2004     NIHR Health Technology Assessment programme Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation
2004     HAYES, Inc. Recombinant human bone morphogenetic protein for use in bone repair
2004     NIHR Health Technology Assessment programme Acupuncture of chronic headache disorders in primary care: randomised controlled trial and economic analysis
2004     HAYES, Inc. Robotically assisted coronary artery bypass surgery
2004     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Evaluation of photodynamic therapy for the treatment of exudative age-related macular degeneration (ARMD) with subfoveal neovascularization
2004     Institute for Clinical Systems Improvement (ICSI) Electron-beam and helical computed tomography for coronary artery disease
2004     NIHR Health Technology Assessment programme Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus
2004     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of prehospital intravenous fluids in trauma patients
2004     NIHR Health Technology Assessment programme Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation
2004     NIHR Health Technology Assessment programme Development and validation of methods for assessing the quality of diagnostic accuracy studies
2004     University of York The management of colorectal cancers
2004     NIHR Health Technology Assessment programme EVALUATE hysterectomy trial: a multicentre randomised trial comparing abdominal, vaginal and laparoscopic methods of hysterectomy
2004     NIHR Health Technology Assessment programme Methods for expected value of information analysis in complex health economic models: developments on the health economics of interferon-beta and glatiramer acetate for multiple sclerosis
2004     Washington State Department of Labor and Industries (WSDLI) Low level laser therapy
2004     Washington State Department of Labor and Industries (WSDLI) Tinnitus retraining therapy
2004     HAYES, Inc. Biosynthetic tissue-engineered skin substitutes for wound healing
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Impact of radiation wait times on risk of local recurrence of breast cancer: early stage cancer with no chemotherapy
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Ximelagatran in prevention of cardiovascular events
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Inteferon-based therapies for chronic Hepatitis C virus infection: an assessment of clinical outcomes
2004     HAYES, Inc. Sodium hyaluronate for osteoarthritis
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Virtual colonoscopy
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Recombinant tissue plasminogen activator (rt-PA) in acute ischemic stroke
2004     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Assessment of the scientific evidence on the use of recombinant activated C protein - (activated) alpha-drotrecogin - in severe sepsis
2004     Belgian Health Care Knowledge Centre (KCE) Leukoreduction. A possible measure in the context of a national blood safety policy
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Pneumatic compression therapy on venous insufficiency
2004     West Midlands Health Technology Assessment Collaboration (WMHTAC) Provocation-neutralisation testing and therapy for food allergy
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Gefitinib for inoperable or recurrent non-small cell lung cancer
2004     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Screening of osteoporosis by densitometry by ultrasound versus ionising techniques by X-rays. Evaluation of clinical utility and usage status in Spain
2004     Institute for Clinical Systems Improvement (ICSI) Extracorporeal shock wave therapy for plantar fasciitis
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Laronidase
2004     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Estimation of cardiovascular risk in primary care
2004     Blue Cross Blue Shield Association (BCBS) Special Report: Genotyping for cytochrome p450 polymorphisms to determine drug-metabolizer status
2004     HAYES, Inc. High-sensitivity C-reactive protein testing for coronary artery disease screening of asymptomatic individuals
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Water jet systems for surgical dissection and resection
2004     Blue Cross Blue Shield Association (BCBS) Botulinum toxin for treatment of primary chronic headache disorders
2004     ECRI Computed tomography for predicting coronary artery disease risk
2004     Blue Cross Blue Shield Association (BCBS) Special Report: The publication of new evidence and effect on physician prescribing behaviors
2004     University HealthSystem Consortium (UHC) 5-HT3 antagonist update (2004)